A Targetable, Injectable Adenoviral Vector for Selective Gene Delivery to Pulmonary Endothelium in Vivo
Paul N. Reynolds(Royal Adelaide Hospital), D T Curiel(Gene Therapy Laboratory), Irina V. Balyasnikova(Northwestern University), Buck E. Rogers(Washington University in St. Louis), Kurt R. Zinn(University of Alabama at Birmingham), David J. Miletich(University of Illinois Chicago), Ming H. Wang(Gene Therapy Laboratory), Sergei M. Danilov(University of Illinois Chicago), V D Gavrilyuk(University of Illinois Chicago), Donald J. Buchsbaum(University of Alabama at Birmingham), W E Grizzle(University of Alabama at Birmingham), Joanne T. Douglas(Gene Therapy Laboratory)
Cited by 202
Related Papers
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals
|Annals of the American Thoracic Society|2018|723
Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function
|The Journal of Immunology|2006|487
Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer
|Clinical Cancer Research|2015|477
Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host
|Blood|2007|328
Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung
|Nature Biotechnology|2007|305